Concepedia

Vanessa Chaire

VC

Statistics

Publications

13

Citations

421

H-Index

13

Active since

2015

Affiliations

Institut Bergonié(Current)

Inserm

Université de Bordeaux

Bordeaux Population Health

Centre National de la Recherche Scientifique

Vanessa Chaire is an author at Institut Bergonié specializing in oncology, medicine, and malignant neoplasms.

ORCID

Publications per year

2015–2024

13

Publications

13

Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas

Audrey Laroche‐Clary, Vanessa Chaire, Marie-Paule Algéo et al. · Journal of Hematology & Oncology · 2017 · 116 citations · Full text

, , +17

High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies

Maud Toulmonde, Carlo Lucchesi, Stéphanie Verbeke et al. · EBioMedicine · 2020 · 59 citations · Full text

, , +17

MDM2 antagonists synergize with PI3K/mTOR inhibition in well-differentiated/dedifferentiated liposarcomas

Audrey Laroche, Vanessa Chaire, Marie-Paule Algéo et al. · Oncotarget · 2017 · 36 citations · Full text

, , +16

PRIMA-1MET induces death in soft-tissue sarcomas cell independent of p53

Thomas Grellety, Audrey Laroche‐Clary, Vanessa Chaire et al. · BMC Cancer · 2015 · 33 citations · Full text

, , +17

Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas

Audrey Laroche, Vanessa Chaire, François Le Loarer et al. · Journal of Hematology & Oncology · 2017 · 29 citations · Full text

, , +17

1–5 of 13